Doctors at AIIMS, Delhi are developing a low-cost antibody-based adaptive cellular therapy for treatment of multiple myeloma, a form of blood cancer.

Duchenne muscular dystrophy (DMD) is one of the most common and devastating childhood genetic disorders, affecting ...

Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite ...

A collaborative effort by experts from, Genentech, and the Chan-Zuckerberg Initiative aims to leverage artificial ...

Eunice S. Wang, MD, discusses the role of transplant eligibility in shaping treatment strategies for secondary acute myeloid leukemia.

According to latest data from National cancer registry, the estimated number of incident cases of cancer in India in 2022 was ...

Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively.

In 2024 hair transplants remain the most reliable solution for severe hair loss offering permanent results However advanced ...

Colorado physicians helped research a new treatment protocol for the most common form of childhood cancer that has “instantly ...